Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Desmopressin Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 20 USDMF, 14 CEP/COS, 2 JDMF, 4 EU WC, 9 KDMF, 27 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

233 FDF Dossiers, 53 FDA Orange Book, 134 Europe, 10 Canada, 12 Australia, 8 South Africa, 16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;NASAL - 0.01%, SPRAY, METERED;NASAL - 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.004MG/ML, TABLET;ORAL - 0.1MG, TABLET;ORAL - 0.2MG, SPRAY, METERED;NASAL - 0.00083MG/SPRAY, SPRAY, METERED;NASAL - 0.00166MG/SPRAY, SPRAY, METERED;NASAL - 0.15MG/SPRAY, SPRAY, METERED;NASAL - 0.01MG/SPRAY, TABLET;SUBLINGUAL - 0.0277MG, TABLET;SUBLINGUAL - 0.0553MG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 1 DKSH, 4 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 2 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 18 Kerry, 10 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 7 Roquette, 5 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 4 Sigachi Industries, 2 Ulanqab Kema New Material, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 18 Direct Compression, 18 Disintegrants & Superdisintegrants, 17 Solubilizers, 14 Granulation, 13 Lubricants & Glidants, 10 Parenteral, 9 Co-Processed Excipients, 8 Controlled & Modified Release, 8 Thickeners and Stabilizers, 7 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 4 Taste Masking, 4 Topical, 4 Surfactant & Foaming Agents, 4 Coating Systems & Additives, 3 Film Formers & Plasticizers, 2 API Stability Enhancers

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 123 Regulatory FDF Prices

MARKET PLACE

9 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 18 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/03/2025	PolyPeptide Group	Switzerland	PolyPeptide Laboratories (Sweden) AB	306MF10047	Desmopressin	2024-03-27	2024-03-27	Ho(¨)gerudsgatan 21, Limhamn
28/03/2025	PolyPeptide Group	Switzerland	PolyPeptide Laboratories (Sweden) AB	224MF10122	Desmopressin	2012-07-09	2023-06-28	Ho(¨)gerudsgatan 21, Limhamn

Desmopressin Acetate

Desmopressin Acetate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers

20 USDMF

14 CEP/COS

2 JDMF

4 EU WC

9 KDMF

27 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

233 FDF Dossiers

53 FDA Orange Book

134 Europe

10 Canada

12 Australia

8 South Africa

16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;NASAL - 0.01%

SPRAY, METERED;NASAL - 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.004MG/ML

TABLET;ORAL - 0.1MG

TABLET;ORAL - 0.2MG

SPRAY, METERED;NASAL - 0.00083MG/SPRAY

SPRAY, METERED;NASAL - 0.00166MG/SPRAY

SPRAY, METERED;NASAL - 0.15MG/SPRAY

SPRAY, METERED;NASAL - 0.01MG/SPRAY

TABLET;SUBLINGUAL - 0.0277MG

TABLET;SUBLINGUAL - 0.0553MG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma

1 DKSH

4 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

2 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

15 BASF

2 DFE Pharma

1 Finar

7 Gangwal Chemicals

2 Ingredion Pharma Solutions

18 Kerry

10 Microlex e.U

2 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

1 Prachin Chemical

7 Roquette

5 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

4 Sigachi Industries

2 Ulanqab Kema New Material

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders

18 Direct Compression

18 Disintegrants & Superdisintegrants

17 Solubilizers

14 Granulation

13 Lubricants & Glidants

10 Parenteral

9 Co-Processed Excipients

8 Controlled & Modified Release

8 Thickeners and Stabilizers

7 Chewable & Orodispersible Aids

7 Emulsifying Agents

SPRAY, METERED;NASAL - 0.01MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons